These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30718159)

  • 1. Performance of the Accelerate Diagnostics Pheno
    Starr KF; Robinson DC; Hazen KC
    Diagn Microbiol Infect Dis; 2019 Jun; 94(2):122-128. PubMed ID: 30718159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Effect of Expedited Pathogen Identification and Susceptibility Testing for Gram-Negative Bacteremia and Candidemia by Use of the Accelerate Pheno
    Burnham JP; Wallace MA; Fuller BM; Shupe A; Burnham CD; Kollef MH
    J Appl Lab Med; 2019 Jan; 3(4):569-579. PubMed ID: 31639726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the Accelerate Pheno System for Identification and Antimicrobial Susceptibility Testing of Pathogens in Positive Blood Cultures and Impact on Time to Results and Workflow.
    Charnot-Katsikas A; Tesic V; Love N; Hill B; Bethel C; Boonlayangoor S; Beavis KG
    J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29118168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility Provision Enhances Effective De-escalation (SPEED): utilizing rapid phenotypic susceptibility testing in Gram-negative bloodstream infections and its potential clinical impact.
    Schneider JG; Wood JB; Schmitt BH; Emery CL; Davis TE; Smith NW; Blevins S; Hiles J; Desai A; Wrin J; Bocian B; Manaloor JJ
    J Antimicrob Chemother; 2019 Jan; 74(Suppl 1):i16-i23. PubMed ID: 30690542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the impact of the Accelerate Pheno™ system on time to result for differing antimicrobial stewardship intervention models in patients with gram-negative bloodstream infections.
    Elliott G; Malczynski M; Barr VO; Aljefri D; Martin D; Sutton S; Zembower TR; Postelnick M; Qi C
    BMC Infect Dis; 2019 Nov; 19(1):942. PubMed ID: 31699044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of novel rapid diagnostic of blood culture identification and antimicrobial susceptibility testing by Accelerate Pheno system and BioFire FilmArray Blood Culture Identification and BioFire FilmArray Blood Culture Identification 2 panels.
    Sze DTT; Lau CCY; Chan TM; Ma ESK; Tang BSF
    BMC Microbiol; 2021 Dec; 21(1):350. PubMed ID: 34922463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of rapid phenotypic identification and antimicrobial susceptibility testing in a pediatric oncology center.
    Brazelton de Cárdenas JN; Su Y; Rodriguez A; Hewitt C; Tang L; Garner CD; Hayden RT
    Diagn Microbiol Infect Dis; 2017 Sep; 89(1):52-57. PubMed ID: 28709731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential influence of rapid diagnostics on timeliness of management decisions for patients with positive blood cultures.
    Grant JM; Porter C; Charles MK; Bryce EA; Wong T; Stefanovic A; Shajari S; Roscoe DL
    J Assoc Med Microbiol Infect Dis Can; 2020 Mar; 5(1):21-28. PubMed ID: 36339013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid identification and susceptibility testing using the VITEK 2 system using culture fluids from positive BacT/ALERT blood cultures.
    Chen JR; Lee SY; Yang BH; Lu JJ
    J Microbiol Immunol Infect; 2008 Jun; 41(3):259-64. PubMed ID: 18629422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Accelerate Pheno™ system for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria in bloodstream infections.
    Descours G; Desmurs L; Hoang TLT; Ibranosyan M; Baume M; Ranc AG; Fuhrmann C; Dauwalder O; Salka W; Vandenesch F
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1573-1583. PubMed ID: 29808350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerate PhenoTest
    Sofjan AK; Casey BO; Xu BA; Amadio J; Restrepo A; Alam MJ; Garey KW
    Ann Pharmacother; 2018 Aug; 52(8):754-762. PubMed ID: 29557208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct antimicrobial susceptibility testing of positive blood cultures: a comparison of the Accelerate Pheno™ and VITEK® 2 systems.
    Schneider JG; Wood JB; Smith NW; Emery CL; Davis TE; Manaloor JJ; Bocian B; Schmitt BH
    Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114841. PubMed ID: 31422873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Accelerate PhenoTest BC Kit and MALDI-TOF MS/VITEK 2 System for the rapid identification and antimicrobial susceptibility testing of gram-negative bacilli causing bloodstream infections.
    Stokes W; Campbell L; Pitout J; Conly J; Church D; Gregson D
    J Assoc Med Microbiol Infect Dis Can; 2020 Oct; 5(3):145-157. PubMed ID: 36341310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Accelerate Pheno System for Fast Identification and Antimicrobial Susceptibility Testing from Positive Blood Cultures in Bloodstream Infections Caused by Gram-Negative Pathogens.
    Marschal M; Bachmaier J; Autenrieth I; Oberhettinger P; Willmann M; Peter S
    J Clin Microbiol; 2017 Jul; 55(7):2116-2126. PubMed ID: 28446572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis.
    Pancholi P; Carroll KC; Buchan BW; Chan RC; Dhiman N; Ford B; Granato PA; Harrington AT; Hernandez DR; Humphries RM; Jindra MR; Ledeboer NA; Miller SA; Mochon AB; Morgan MA; Patel R; Schreckenberger PC; Stamper PD; Simner PJ; Tucci NE; Zimmerman C; Wolk DM
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29305546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Accelerate Pheno and BacT/Alert Virtuo on Clinical Processes and Outcomes in Patients with Sepsis and Concurrent Gram-Negative Bacteremia.
    Babowicz F; LaPlante R; Mitchell C; O'Donnell JN; Tobin E; George M; Carreno JJ
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33753337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial identification and automated antibiotic susceptibility testing directly from positive blood cultures using MALDI-TOF MS and VITEK 2.
    Wattal C; Oberoi JK
    Eur J Clin Microbiol Infect Dis; 2016 Jan; 35(1):75-82. PubMed ID: 26597941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled comparison of the BacT/ALERT® 3D and VIRTUO™ microbial detection systems.
    Totty H; Ullery M; Spontak J; Viray J; Adamik M; Katzin B; Dunne WM; Deol P
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1795-1800. PubMed ID: 28500506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist-Driven Implementation of Fast Identification and Antimicrobial Susceptibility Testing Improves Outcomes for Patients with Gram-Negative Bacteremia and Candidemia.
    Sheth S; Miller M; Prouse AB; Baker S
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Accelerate Pheno System: Results from Two Academic Medical Centers.
    Lutgring JD; Bittencourt C; McElvania TeKippe E; Cavuoti D; Hollaway R; Burd EM
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.